Tzu-Chieh Ho, PhD1*, Craig T Jordan, PhD2, Mark W. LaMere, BA3*, John M. Ashton, PhD3*, Kristen O'Dwyer, MD3*, Jason H. Mendler, MD, PhD4, Jane L. Liesveld, MD5, Eunice S. Wang, MD6, Monica L. Guzman, PhD7, Laura M. Calvi, MD3 and Michael W. Becker, MD3
1Molecular Pharmacology Program, Memorial Sloan-Kettering Cancer Center, New York, NY
2Division of Hematology, University of Colorado School of Medicine, Aurora, CO
3James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
4J.P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
5James P. Wilmot Cancer Institute, Department of Medicine, University of Rochester Medical Center, Rochester, NY
6Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
7Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY